117 related articles for article (PubMed ID: 7579511)
1. Prognostic significance of heat-shock protein-27 in node-positive breast carcinoma: an immunohistochemical study.
Têtu B; Brisson J; Landry J; Huot J
Breast Cancer Res Treat; 1995; 36(1):93-7. PubMed ID: 7579511
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of heat shock proteins 27 and 70 in patients with squamous cell carcinoma of the esophagus.
Kawanishi K; Shiozaki H; Doki Y; Sakita I; Inoue M; Yano M; Tsujinaka T; Shamma A; Monden M
Cancer; 1999 Apr; 85(8):1649-57. PubMed ID: 10223556
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of HER-2/neu oncoprotein expression in node-positive breast cancer. The influence of the pattern of immunostaining and adjuvant therapy.
Têtu B; Brisson J
Cancer; 1994 May; 73(9):2359-65. PubMed ID: 7909490
[TBL] [Abstract][Full Text] [Related]
4. Stress response protein (srp-27) determination in primary human breast carcinomas: clinical, histologic, and prognostic correlations.
Thor A; Benz C; Moore D; Goldman E; Edgerton S; Landry J; Schwartz L; Mayall B; Hickey E; Weber LA
J Natl Cancer Inst; 1991 Feb; 83(3):170-8. PubMed ID: 1988702
[TBL] [Abstract][Full Text] [Related]
5. A 27 kDa heat shock protein that has anomalous prognostic powers in early and advanced breast cancer.
Love S; King RJ
Br J Cancer; 1994 Apr; 69(4):743-8. PubMed ID: 8142264
[TBL] [Abstract][Full Text] [Related]
6. Significance of heat shock protein-27 expression in patients with renal cell carcinoma.
Erkizan O; Kirkali G; Yörükoğlu K; Kirkali Z
Urology; 2004 Sep; 64(3):474-8. PubMed ID: 15351573
[TBL] [Abstract][Full Text] [Related]
7. Cysteine proteinase inhibitor cystatin A in breast cancer.
Kuopio T; Kankaanranta A; Jalava P; Kronqvist P; Kotkansalo T; Weber E; Collan Y
Cancer Res; 1998 Feb; 58(3):432-6. PubMed ID: 9458085
[TBL] [Abstract][Full Text] [Related]
8. Heat shock protein 27 overexpression in breast cancer lymph node metastasis.
Storm FK; Mahvi DM; Gilchrist KW
Ann Surg Oncol; 1996 Nov; 3(6):570-3. PubMed ID: 8915490
[TBL] [Abstract][Full Text] [Related]
9. p53 protein accumulation detected by five different antibodies: relationship to prognosis and heat shock protein 70 in breast cancer.
Elledge RM; Clark GM; Fuqua SA; Yu YY; Allred DC
Cancer Res; 1994 Jul; 54(14):3752-7. PubMed ID: 8033095
[TBL] [Abstract][Full Text] [Related]
10. Colocalization of estrogen and progesterone receptors with an estrogen-regulated heat shock protein in paraffin sections of human breast and endometrial cancer tissue.
Ciocca DR; Stati AO; Amprino de Castro MM
Breast Cancer Res Treat; 1990 Oct; 16(3):243-51. PubMed ID: 2085675
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical detection of HER2/neu in patients with axillary lymph node negative breast carcinoma. A study of epidemiologic risk factors, histologic features, and prognosis.
Rosen PP; Lesser ML; Arroyo CD; Cranor M; Borgen P; Norton L
Cancer; 1995 Mar; 75(6):1320-6. PubMed ID: 7882282
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical expression of the mucin-type glycoprotein A-80 and prognosis in human breast cancer.
Eriksson ET; Schimmelpenning H; Rutqvist LE; Johansson H; Auer GU
Br J Cancer; 1993 Jun; 67(6):1418-22. PubMed ID: 8512827
[TBL] [Abstract][Full Text] [Related]
13. TIF1γ interferes with TGFβ1/SMAD4 signaling to promote poor outcome in operable breast cancer patients.
Kassem L; Deygas M; Fattet L; Lopez J; Goulvent T; Lavergne E; Chabaud S; Carrabin N; Chopin N; Bachelot T; Gillet G; Treilleux I; Rimokh R
BMC Cancer; 2015 Jun; 15():453. PubMed ID: 26040677
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical detection of estrogen receptor in invasive human breast cancer: correlation with heat shock proteins, pS2 and oncogene products.
Takahashi S; Narimatsu E; Asanuma H; Okazaki M; Okazaki A; Hirata K; Mori M; Chiba T; Sato N; Kikuchi K
Oncology; 1995; 52(5):371-5. PubMed ID: 7637953
[TBL] [Abstract][Full Text] [Related]
15. Heat shock protein hsp70 in patients with axillary lymph node-negative breast cancer: prognostic implications.
Ciocca DR; Clark GM; Tandon AK; Fuqua SA; Welch WJ; McGuire WL
J Natl Cancer Inst; 1993 Apr; 85(7):570-4. PubMed ID: 8455204
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of cathepsin-D expression in node-positive breast carcinoma: an immunohistochemical study.
Têtu B; Brisson J; Côté C; Brisson S; Potvin D; Roberge N
Int J Cancer; 1993 Sep; 55(3):429-35. PubMed ID: 8397164
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical localization of cathepsin D, proliferating cell nuclear antigen and epidermal growth factor receptor in human breast carcinoma analysed by computer image analyser: correlation with histological grade and metastatic behaviour.
Okamura K; Kobayashi I; Matsuo K; Kiyoshima T; Yamamoto K; Miyoshi A; Sakai H
Histopathology; 1997 Dec; 31(6):540-8. PubMed ID: 9447385
[TBL] [Abstract][Full Text] [Related]
18. Oestrogen receptor, progesterone receptor, pS2, ERD5, HSP27 and cathepsin D in invasive ductal breast carcinomas.
Hurlimann J; Gebhard S; Gomez F
Histopathology; 1993 Sep; 23(3):239-48. PubMed ID: 8225242
[TBL] [Abstract][Full Text] [Related]
19. The prognostic significance of expression of the multidrug resistance-associated protein (MRP) in primary breast cancer.
Nooter K; Brutel de la Riviere G; Look MP; van Wingerden KE; Henzen-Logmans SC; Scheper RJ; Flens MJ; Klijn JG; Stoter G; Foekens JA
Br J Cancer; 1997; 76(4):486-93. PubMed ID: 9275026
[TBL] [Abstract][Full Text] [Related]
20. Localization of metallothionein in breast carcinomas. An immunohistochemical study.
Fresno M; Wu W; Rodriguez JM; Nadji M
Virchows Arch A Pathol Anat Histopathol; 1993; 423(3):215-9. PubMed ID: 8236816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
